Incyte (INCY) Other Non Operating Income (2017 - 2026)

Incyte (INCY) reported Other Non Operating Income of $2.8 million for Q1 2026, down 65.74% on a YoY basis from $8.1 million in Q1 2025, and down 51.02% quarter-over-quarter from $5.7 million in Q4 2025.

Incyte (INCY) Other Non Operating Income (2017 - 2026) Analysis & Trends

Incyte has reported Other Non Operating Income for 10 years, with the latest figure at $2.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income fell 65.74% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $19.8 million (down 13.71% YoY), and the FY2025 full-year result was $25.1 million, up 96.03% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $2.8 million, down from $5.7 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $46.4 million in Q3 2023, with the low at -$108.0 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged $3.2 million across 5 years, with a median of $4.9 million in 2024.
  • The largest YoY upside for Other Non Operating Income was 8073.95% in 2023 against a maximum downside of 681.66% in 2023.
  • Incyte's Other Non Operating Income stood at -$13.8 million in 2022, then tumbled by 681.66% to -$108.0 million in 2023, then jumped by 101.49% to $1.6 million in 2024, then jumped by 251.15% to $5.7 million in 2025, then slumped by 51.02% to $2.8 million in 2026.
  • The last three Other Non Operating Income figures came in at $2.8 million (Q1 2026), $5.7 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.77 Mn
Dec 31, 2025 5.66 Mn
Sep 30, 2025 4.04 Mn
Jun 30, 2025 7.31 Mn
Mar 31, 2025 8.10 Mn
Dec 31, 2024 1.61 Mn
Sep 30, 2024 4.93 Mn
Jun 30, 2024 8.29 Mn
Mar 31, 2024 -2.03 Mn
Dec 31, 2023 -107.98 Mn
Sep 30, 2023 46.37 Mn
Jun 30, 2023 42.67 Mn
Mar 31, 2023 32.87 Mn
Dec 31, 2022 -13.81 Mn
Sep 30, 2022 11.51 Mn
Jun 30, 2022 522,000.00
Mar 31, 2022 1.26 Mn
Dec 31, 2021 5.72 Mn
Sep 30, 2021 1.95 Mn
Jun 30, 2021 4.39 Mn